The Guardian15 jun 2026Macro
Automatisch samengesteld met AI uit de vermelde bronnen
Sigma’s withdrawal from a potential takeover estimated at $10bn (£7bn) for the 1,800-store UK pharmacy chain was announced Monday, with the Australian group stating the deal would not meet its strategic and capital investment objectives. The news prompted a 6% rally in Sigma shares, a reaction one strategist attributed to investor relief that management would focus on existing opportunities. Boots, which reported £337m pre-tax profit on £7.5bn revenue for the year to August 2025, has been under a formal sale process since 2022.